Open AccessAlemtuzumab Treatment Leads to Delayed Recovery of T Follicular Regulatory Cells, and May Therefore Predispose Patients to de novo Donor-Specific Antibody Formation
Author(s) -
Elizabeth Wallin,
Michelle Linterman,
Kathryn J. Wood
Publication year - 2019
Publication title -
obm transplantation
Language(s) - English
Resource type - Journals
ISSN - 2577-5820
DOI - 10.21926/obm.transplant.1903079
Subject(s) - alemtuzumab , cd52 , immunosuppression , immunology , antibody , population , monoclonal antibody , medicine , transplantation , biology , environmental health